Singapore markets open in 6 hours 42 minutes

Cassava Sciences, Inc. (SAVA)

NasdaqCM - NasdaqCM Real-time price. Currency in USD
Add to watchlist
11.79-0.26 (-2.16%)
As of 02:18PM EDT. Market open.
Full screen
Trade prices are not sourced from all markets
Previous close12.05
Bid11.80 x 100
Ask11.81 x 100
Day's range11.65 - 12.35
52-week range8.79 - 32.10
Avg. volume2,027,777
Market cap565.639M
Beta (5Y monthly)-0.57
PE ratio (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend date13 Dec 2012
1y target estN/A
  • Zacks

    Biotech Stock Roundup: LXRX Up on Regulatory Update, SAVA, LXEO Down on Updates

    Cassava Sciences, Inc. (SAVA) and Lexeo Therapeutics (LXEO) are in the spotlight following updates.

  • Benzinga

    Cassava Sciences Faces Leadership Shake-Up, Prioritizes Transparency And Scientific Rigor In Alzheimer's Trials

    Cassava Sciences Inc (NASDAQ:SAVA) stock is trading lower on Wednesday on a heavy session volume of 14.35 million, as per data from Benzinga Pro. The Board of Directors appointed Richard (Rick) Barry as Executive Chairman and the company’s principal executive officer, effective immediately. The company is searching for a new permanent CEO. Mr. Barry succeeds Remi Barbier, the Company’s Chairman, President, and CEO, who resigned and will remain employed by the Company until September 13, 2024, in

  • Yahoo Finance Video

    Cassava forms committee after US probe, researcher fraud

    Cassava Sciences (SAVA) is reportedly forming a committee to investigate two senior employees. This comes after a US probe into fraud and a Cassava researcher was indicted by a jury over alleged fabrication of Alzheimer's drug trial results. For more expert insight and the latest market action, click here to watch this full episode of Market Domination. This post was written by Luke Carberry Mogan.